(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Corvus Pharmaceuticals is 1160530
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Fri May 2025 | 4.43 | 4.22 | 4.49 | 3.93 | 7.63 times |
| 08 Thu May 2025 | 3.35 | 3.19 | 3.49 | 3.17 | 4.058 times |
| 07 Wed May 2025 | 3.20 | 3.38 | 3.38 | 3.17 | 0.677 times |
| 06 Tue May 2025 | 3.35 | 3.56 | 3.56 | 3.33 | 0.627 times |
| 05 Mon May 2025 | 3.57 | 3.58 | 3.66 | 3.52 | 0.463 times |
| 02 Fri May 2025 | 3.62 | 3.67 | 3.71 | 3.59 | 0.973 times |
| 01 Thu May 2025 | 3.52 | 3.58 | 3.58 | 3.47 | 0.55 times |
| 30 Wed Apr 2025 | 3.59 | 3.57 | 3.67 | 3.51 | 0.415 times |
| 29 Tue Apr 2025 | 3.62 | 3.50 | 3.69 | 3.41 | 1.004 times |
| 28 Mon Apr 2025 | 3.50 | 3.70 | 3.76 | 3.48 | 0.626 times |
Stock of Corvus Pharmaceuticals (CRVS) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 4.1, for a target of 3.7 or 3.44
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 2.54 |
| Downside Target | 3.08 |
| Downside Target | 3.27 |
| Downside Target | 3.41 |
| Downside Target | 3.76 |
| Downside Target | 3.85 |
| Upside Target | 4.49 |
| Upside Target | 4.60 |
| Upside Target | 4.80 |
| Upside Target | 5.65 |
| Upside Target | 6.47 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 3.57 |
| Downside Intraday Target | 2.71 |
| Upside Intraday Target | 4.89 |
| Upside Intraday Target | 5.35 |
| Downside Intraday Target | 4.03 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Fri May 2025 | 4.43 | 3.58 | 4.49 | 3.17 | 3.773 times |
| 02 Fri May 2025 | 3.62 | 3.70 | 3.76 | 3.41 | 0.868 times |
| 25 Fri Apr 2025 | 3.63 | 3.21 | 3.78 | 3.15 | 6.154 times |
| 17 Thu Apr 2025 | 3.24 | 3.19 | 3.32 | 3.11 | 0.98 times |
| 16 Wed Apr 2025 | 3.23 | 3.19 | 3.27 | 3.11 | 0.385 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Fri May 2025 | 4.43 | 3.58 | 4.49 | 3.17 | 0.972 times |
| 30 Wed Apr 2025 | 3.59 | 3.22 | 3.78 | 2.54 | 1.648 times |
| 31 Mon Mar 2025 | 3.18 | 4.10 | 4.80 | 3.08 | 1.037 times |
| 28 Fri Feb 2025 | 4.04 | 5.17 | 5.65 | 3.85 | 0.874 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.88 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.88 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.